Tech Company Inital Public Offerings
Century Therapeutics IPO
Century Therapeutics was acquired by . Shares were listed on 6/22/2021.
Transaction Overview
Company Name
Announced On
6/22/2021
Transaction Type
IPO
Amount
$211,000,000
Proceeds Purpose
Proceeds will be used to fund pre-clinical activities and clinical preparation activities for product candidates, as well as to continue developing manufacturing capabilities and to fund internal research and development capabilities.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3675 Market St.
Philadelphia, PA 19104
USA
Philadelphia, PA 19104
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Century Therapeutics is developing novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies. Our commitment to developing accessible cell therapies provides an unparalleled opportunity to advance the course of cancer care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lalo Flores
Chief Scientific Officer
Luis Borges
Chief Technical Officer
Gregory Russotti
Vice President
Kenneth Dow
VP - Bus. Development
Janelle Anderson
VP - Bus. Development
Michael Diem
VP - Bus. Development
Adrienne Farid
VP - Engineering
Michael Naso
VP - Finance
Douglas Carr
VP - Human Resources
Shane Williams
VP - Manufacturing
Carl Burke
VP - R & D
Hy Levitsky
Browse more venture capital transactions:
Prev: 6/22/2021: WaitWhat venture capital transaction
Next: 6/22/2021: Lexion venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions on this site are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs